Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons - NCT00996970-78234 (Clinical Trial 369774)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy369774.aspx
|
** Please review additional "Nearby Studies" on right ----->
This is an archived study that is no longer available, if you
would like to find active studies please
search our studies.
|
|
 |
 |
|
| City: |
|
Fort Sam Houston |
|
State:
|
|
TX |
| Zip Code: |
|
78234 |
| Conditions: |
|
Influenza - H1N1 - HIV - Vaccine - HIV Infections |
| Purpose: |
|
The purpose of this research is to determine the effectiveness of the novel H1Nl influenza
(inactivated/killed formulation) vaccine among both HIV-infected and HIV-uninfected persons.
The administration of the H1Nl vaccination is not part of the study's procedures, but is
being given as part of routine care.
|
| Study summary: |
|
Our study is being conducted to evaluate and compare the seroresponses of the novel H1N1
vaccination among HIV positive and negative persons receiving the novel H1N1 vaccination as
part of routine clinical care, with secondary objectives examining the impact of prior
seasonal vaccinations on subsequent seroresponse to the novel H1N1 vaccination, determining
potential reactions (local or systemic) to this new vaccine among patients, and assessing
for potential immunologic/virologic changes (in CD4/HIV RNA levels) after H1N1 vaccination
among HIV patients. Finally, we will collect data on influenza-like illnesses (ILI) and H1N1
events during the study follow-up period and influenza isolates causing ILI events will be
genetically characterized. |
| Criteria: |
|
Inclusion Criteria:
- 18-50 years of age
- Receiving the novel H1N1 vaccine (killed formulation) as part of routine clinical
care
- A military beneficiary who expects to remain in the local area for the next 6 months
Exclusion Criteria:
- Healthcare worker who is involved in direct patient care
- Acute febrile illnesses within 30 days prior to H1N1 vaccination (e.g., pneumonia,
influenza, ILI)
- Diabetes type 1 or type 2
- Systemic steroid or immunosuppressive medication use within 4 weeks of vaccination
- Active diagnoses of a cancer (non-melanoma skin cancer allowed).
- History of organ transplant
- Chronic active hepatitis B or C
- Active illicit drug use or alcohol abuse
- Blood transfusion within the last year
- Allergy to eggs
- Previous significant adverse reaction (e.g., anaphylaxis) to the seasonal influenza
vaccination
- History of serious reactions to any prior vaccination (e.g., Guillain Barre Syndrome
(GBS)).
- Received another vaccination in the last 4 weeks (receipt of seasonal influenza
vaccination is allowed)
- Among females of childbearing potential, pregnant or within 6 weeks of being
postpartum
- History of ILI which was confirmed as an H1N1 infection |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
December 30, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|